Jena, Germany

Axel Gohring

This inventor holds 1 USPTO granted patent. Top assignee: Universitatsklinikum Jena. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Axel Gohring. Retrieved from https://idiyas.com/inventor/axel-gohring

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Axel Gohring: Innovator in Cancer Treatment

Introduction

Axel Gohring is a notable inventor based in Jena, Germany. He has made significant contributions to the field of cancer treatment through his innovative research and patents. His work focuses on the use of microRNAs for therapeutic applications in malignant tumors.

Latest Patents

Axel Gohring holds a patent titled "Human microRNAs for treatment of malignant tumours." This invention relates to a nucleic acid molecule designed for use in a method of treating cancer. The nucleic acid molecule comprises a sequence selected from SEQ ID NO 001 to SEQ ID NO 038. It is important to note that the nucleic acid molecules provided are not intended for the treatment of laryngeal cancer. He has 1 patent to his name.

Career Highlights

Gohring is affiliated with Universitätsklinikum Jena, where he continues to advance his research in oncology. His work has garnered attention for its potential impact on cancer therapies, particularly in the realm of genetic treatments.

Collaborations

One of his notable collaborators is Ralf Mrowka, with whom he has worked closely on various projects related to cancer research.

Conclusion

Axel Gohring's contributions to cancer treatment through his innovative patent highlight the importance of research in developing new therapeutic strategies. His work continues to inspire advancements in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…